Appleton, WI, United States of America

Laura Biesterveld


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Laura Biesterveld: Innovator in Pharmaceutical Composition

Introduction

Laura Biesterveld is a notable inventor based in Appleton, WI (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at combating cancer. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to improving health outcomes.

Latest Patents

Laura Biesterveld holds a patent for a pharmaceutical composition comprising oxidizable biphenol and manganese porphyrin, along with a method of using the same. This composition is designed for killing cancer cells and includes effective amounts of one oxidizable diphenol and a manganese porphyrin in either a one-part or two-part dosage form. The administration of these components can occur simultaneously or sequentially to a subject in need, highlighting the versatility and potential effectiveness of her invention.

Career Highlights

Laura is affiliated with Villanova University, where she continues to engage in research and development in her field. Her work not only reflects her innovative spirit but also her commitment to advancing medical science. With a patent to her name, she stands out as a key figure in the pharmaceutical industry.

Collaborations

Laura collaborates with talented individuals such as Aimee Eggler and Sandra Tamarin. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Laura Biesterveld is a pioneering inventor whose work in pharmaceutical compositions demonstrates her commitment to fighting cancer. Her innovative approach and collaboration with esteemed colleagues position her as a significant contributor to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…